Key Documents
Robert Lowsky
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Division: Blood and Marrow Transplantation
- Member, Cancer Center
Contact Information
-
Clinical Offices
Blood and Marrow Transplantation 875 Blake Wilbur Dr Clinic E Stanford, CA 94305-5820 Tel Work (650) 723-0822 Fax (650) 725-8950
-
Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > Bone Marrow Transplant
- Cancer > Hematology
- Blood and Marrow Transplantation
- Hematology
Professional Education
| Fellowship: | Toronto General Hospital, Canada (1993) |
| Board Certification: | Internal Medicine, Royal College of Physicians and Surgeons (1992) |
| Residency: | Toronto General Hospital, Canada (1991) |
| Internship: | Toronto General Hospital, Canada (1989) |
| Medical Education: | McGill University, Canada (1988) |
Scientific Focus
Research Interests
Dr. Lowsky's research is focused on understanding the role of regulatory T cells in the prevention of GVHD and in promoting immune tolerance following organ transplantation.
Clinical Trials
- Allogeneic HCT using Nonmyeloablative Host Conditioning with TLI & ATG vs SOC in AML Recruiting
- Allogeneic Hematopoietic Cell Transplantation Using TLI/ATG for Older Patients with Hematologic Malignancies Recruiting
- Allogeneic Transplantation From Related Haploidentical Donors in Older Patients with Indolent Hematologic Malignancies Recruiting
- TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD Recruiting
- A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft versus Host Disease Recruiting
Publications
- Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update. Curr Opin Hematol. 2009; (6): 460-5
- TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood. 2009; (5): 1099-109
- Total lymphoid irradiation for graft-versus-host disease protection. Curr Opin Oncol. 2009: S23-6
- Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med. 2008; (4): 362-8
- High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant. 2006; (7): 703-11
Trial Administration